• home
  • Program
  • Program at a Glance

Program at a Glance

Day 1: August 31 (Thursday)

  Auditorium (2F) Room A (2F) Room B (2F) Room C (1F) Room D (1F)
09:00-09:30 Opening Ceremony        
09:30-10:50 Plenary Session 1
State of the Art in Cell Therapy
       
10:50-11:00 Break
11:00-12:20 Plenary Session 2
Alternative Donors
       
12:20-12:30 Break
12:30-13:10   Luncheon Symposium 1
Luncheon Symposium 2
Luncheon Symposium 3
Luncheon Symposium 4

(Room D-1)
Luncheon Symposium 5

(Room D-2)
13:10-13:20 Break
13:20-14:50 Joint Symposium 1
ASTCT-KSBMT

Is HSCT still Relevant in Immunotherapy Era for Lymphoid Malignancies?
Scientific Session 1
Dealing with Practical Issues of Transplantation in Aplastic Anemia
Education Session 1
Pathogenesis, Diagnosis, Treatment of Endothelial Damage Syndrome
Nursing Session 1
(Kor.)
14:50-15:00 Break
15:00-16:00 Oral 1 Oral 2 Oral 3 Oral 4
16:00-16:10 Break
16:10-16:30 Poster
16:30-16:40 Break
16:40-18:10 Joint Symposium 2
TSBMT-KSBMT

Experiences and Future Perspectives on Transplantation and Cellular Therapy for Multiple Myeloma
(16:40-17:40)
Scientific Session 2
Immunotherapy for Lymphoid Malignancy in the Post-CART Era
Scientific Session 3
Transplantation Related Immunology
Education Session 2
Conditioning Regimen in Transplant Setting
18:30- Welcome Reception
(Nurimaru APEC House)

Day 2: September 1 (Friday)

  Auditorium (2F) Room A (2F) Room B (2F) Room C (1F) Room D (1F)
09:00-10:30   Scientific Session 4
Divergent Approaches to the Use of Autologous Hematopoietic Stem Cell Transplantation
Scientific Session 5
GVHD in 2023: From Prediction to Prevention
Scientific Session 6
New Insights in the Immune Effector Cell Therapies for Multiple Myeloma
Scientific Session 7
Strategies for Successful Cord Blood Transplantation
10:30-10:40 Break (10:30-10:50) Break (10:30-10:50)
10:40-10:50 Break (10:40-10:50) Break (10:40-10:50)
10:50-11:30 Plenary Session 3
HSCT in myeloid
 
11:30-12:10 Presidential Symposium
New insights and challenges in managing chronic GVHD
12:10-12:20 Break
12:20-13:00   Luncheon Symposium 6
Luncheon Symposium 7
Luncheon Symposium 8
Luncheon Symposium 9
13:00-13:10 Break
13:10-14:40   Joint Symposium 3
EBMT-KSBMT

Recent Issues in HSCT and Cellular Therapy for ALL
Scientific Session 8
Bone Marrow Microenvironment in Hematologic Malignancy
Education Session 3
Prevention and Management Of Virus Disease in HSCT Patients
Debate Session 1 & 2 (Kor.)
* Simultaneous Korean-English interpreting will be provided
14:40-14:50 Break (14:40-15:00)
14:50-15:00 Break (14:50-15:00) Break (14:50-15:00)
15:00-16:00 Oral 5 Oral 6 Oral 7 Oral 8
16:00-16:10 Break
16:10-16:30 Poster
16:30-16:40 Break
16:40-18:10 Joint Symposium 4
East Asia Collaborative Session

Current Status of CAR-T Cell Therapy: Real-World Practice and Clinical Trials
Scientific Session 9
Finding New Era of Haploidentical HSCT
Scientific Session 10
Data to Clinic for Better Stem Cell Transplantation
Education Session 4
Current and Future Direction in Chronic GVHD
18:10-18:20      
18:45- Gala Dinner
(Paradise Hotel Busan, 2F))

Day 3: September 2 (Saturday)

  Auditorium (2F) Room A (2F) Room B (2F) Room C (1F) Room D (1F)
07:30-09:00   KSBMT Business Meeting  
09:00-10:30   Joint Symposium 5
ISCT-KSBMT

Industry-Academia Bridging in Cellular Therapy: Synergies and Challenges
Scientific Session 11
Pediatric Leukemia: Recent Advances in Treatments
Scientific Session 12
Optimizing HSCT Outcomes in Patients with High-Risk AML
 
10:30-10:40 Break
10:40-12:20 Joint Symposium 6
JSTCT-KSBMT

Recent Updates on the Management of MDS and JMML
Scientific Session 13
Recent Advances in Cellular Immunotherapy
Nursing Session 2
(Kor.)
Break (12:10-12:30)
12:20-12:30 Break (12:20-12:30)  
12:30-12:40 Closing Ceremony  
12:40-13:10 KSBMT General Assembly

Organized by

Supported by

Sponsors

  • >